Last May, three international experts carried out an audit to evaluate the Institute's human resources performance. Nearly 40 research and management1
Next Wednesday, June 22, a meeting will be held to recount the diseases and present the clinical trials.
Treatment with trastuzumab deruxtecan, a combination of a targeted therapy with chemotherapy, increases progression-free survival of the disease and1
So far, the papillomavirus vaccine schedule in Catalonia has been for girls of 11-12 years old only. However, from next year, the Department of Healt1
IDIBAPS is promoting different programs to facilitate professionals combining patient care with biomedical research or enjoying periods of intensive1
On Tuesday, May 31, a group of 9 journalists visited the Institute to learn about the research being carried out.
Researchers at the Hospital Clínic-IDIBAPS and the University of Barcelona have published a review article in the journal Nature Cancer in which they1
The award, granted by the Academy of Medical and Health Sciences of Catalonia and the Balearic Islands, recognizes Novials' research career in the fi1
Researchers from Hospital Clínic-IDIBAPS have participated in the work published by the journal Nature Medicine.
The IDIBAPS research group Pathogenesis of neuronal autoimmune diseases, led by Josep Dalmau, and the company EUROIMMUN Medizinische Labordiagnostika1